Aztech Global - CGS-CIMB Research 2021-09-03: Opportunity To ADD On Weakness

AZTECH GLOBAL LTD. (SGX:8AZ) | SGinvestors.io AZTECH GLOBAL LTD. (SGX:8AZ)

Aztech Global - Opportunity To ADD On Weakness

  • Aztech's share price has fallen 16.4% from its IPO price of S$1.28, and 15.7% from its 1H21 results announcement’s closing price of S$1.27.
  • We think Aztech is currently managing the COVID-19 challenge and component shortages well though these do pose earnings downside risks.
  • Hence, we reiterate our ADD call and target price of S$1.82 for Aztech as we expect stronger 2H21F earnings to re-rate its share price.



Keeping COVID-19 in check

  • Aztech (SGX:8AZ) has so far not faced any major disruptions to its production output despite the high number of COVID-19 cases in Malaysia. Aztech is managing the situation by ramping up its production capacity in China to cover any shortfall in the Malaysian factory.
    • In China, 100% of its eligible employees have had their COVID-19 vaccination, of which 87% had completed their second dose.
    • In Malaysia, about 33% of its eligible employees have been vaccinated against COVID-19, of which 5% has completed the full vaccination regime. Other than putting in place safe management practices, Aztech has encouraged its employees to apply for their own vaccination under the national vaccination programme.


Supply chain disruption could affect 2H21F earnings

  • As at 30 July 2021, Aztech’s order book was not lose any orders but see some orders being pushed into 1H22F.


Concerns priced in - ADD Aztech






William TNG CFA CGS-CIMB Research | Darren ONG CGS-CIMB Research | https://www.cgs-cimb.com 2021-09-03
SGX Stock Analyst Report ADD MAINTAIN ADD 1.820 SAME 1.820



Advertisement



MOST TALKED ABOUT STOCKS / REITS OF THE WEEK



loading.......



ANALYSTS SAY


loading.......